Effects of tiotropium on lung function in current smokers and never smokers with asthma Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
Comparative study of respiratory symptoms, lung function, BMI and exercise capacity in patients with COPD associated with tobacco smoke (TS) and biomass smoke (BS) exposure Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care Year: 2012
Does prolidase activity an early marker for lung emphysema in biomass smoke exposured women Source: International Congress 2016 – The indoor and ambient environments Year: 2016
The influence of smoking on the temperature of the exhaled air in patients with chronic lung diseases Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
The effects of bronchodilators on regional lung sound distribution in patients with COPD Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Environmental tobacco smoke and health in the elderly Source: Eur Respir J 2002; 19: 172-181 Year: 2002
Prediction of exercise capacity using impulse oscillation system in patients with COPD Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013
The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015
The effects of diesel exhausted particles on the oxidative systems in smoking-induced emphysema model Source: Annual Congress 2013 –Indoor and outdoor pollutants: ventilation, sprays, diesel particles, asthma and COPD Year: 2013
Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016
Glycopyrronium significantly improves lung function, dyspnea and health status in COPD patients in all GOLD groups Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
The Evaluation of nutritional status of stable COPD patients and to investigate the effect of nutritional status on perception of dyspnea, exercise capacity, body composition, hospitalisation and life quality Source: International Congress 2014 – Clinical presentations Year: 2014
Lower probability of FEV1 improvement in asthmatic children exposed to passive smoke Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia Year: 2015
COPD, obesity and non-invasive ventilation Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013
Phenotypic comparison of glucose and cardiac physiology of biomass fuel induced and smoking induced COPD Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013
Oral and nasal microbiota in healthy, tobacco smoke COPD (TSCOPD) and biomass smoke COPD (BMSCOPD) subjects from India Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016
Hypogonadism as a factor influencing health condition in COPD patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy Source: International Congress 2016 – Pulmonary drug delivery Year: 2016
QAW039 (fevipiprant) improves lung function and control of asthma symptoms in patients with more severe air flow limitation: A proof-of-concept study Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015
Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease Source: International Congress 2016 – Smoking-related diseases Year: 2016